The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study

被引：0
|
作者：
Ann Christina Eriksen
Flemming B. Sørensen
Jan Lindebjerg
Henrik Hager
René dePont Christensen
Sanne Kjær-Frifeldt
Torben F. Hansen
机构：
[1] Vejle Hospital,Danish Colorectal Cancer Center South
[2] University of Southern Denmark,Institute of Regional Health Research
[3] Lillebaelt Hospital,Department of Pathology
[4] University Institute of Pathology,Department of Clinical Medicine
[5] Aarhus University Hospital,Research Unit of General Practice
[6] University of Aarhus,undefined
[7] Danish Colorectal Cancer Group (DCCG),undefined
[8] University of Southern Denmark,undefined
来源：
International Journal of Colorectal Disease | 2018年 / 33卷
关键词：
Colon cancer stage II; Prognostic markers; Survival; Tumour budding; Tumour stroma ratio;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1115 / 1124
页数：9
相关论文
共 50 条
  • [1] The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study
    Eriksen, Ann Christina
    Sorensen, Flemming B.
    Lindebjerg, Jan
    Hager, Henrik
    Christensen, Ren dePont
    Kjaer-Frifeldt, Sanne
    Hansen, Torben F.
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2018, 33 (08) : 1115 - 1124
  • [2] Prognostic value of tumour infiltrating lymphocytes in stage II colon cancer. A nationwide population-based study.
    Eriksen, Ann Christina
    Sorensen, Flemming Brandt
    Lindebjerg, Jan
    Hager, Henrik
    Christensen, Rene dePont
    Kjaer-Frifeldt, Sanne
    Hansen, Torben
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [3] The Prognostic Value of Tumor-Infiltrating lymphocytes in Stage II Colon Cancer. A Nationwide Population-Based Study
    Eriksen, Ann C.
    Sorensen, Flemming B.
    Lindebjerg, Jan
    Hager, Henrik
    Christensen, Rene dePont
    Kjaer-Frifeldt, Sanne
    Hansen, Torben F.
    TRANSLATIONAL ONCOLOGY, 2018, 11 (04): : 979 - 987
  • [4] Tumour-stroma ratio outperforms tumour budding as biomarker in colon cancer: a cohort study
    Smit, Marloes A.
    van Pelt, Gabi W.
    Terpstra, Valeska
    Putter, Hein
    Tollenaar, Rob A. E. M.
    Mesker, Wilma E.
    van Krieken, J. Han J. M.
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2021, 36 (12) : 2729 - 2737
  • [5] Tumour-stroma ratio outperforms tumour budding as biomarker in colon cancer: a cohort study
    Marloes A. Smit
    Gabi W. van Pelt
    Valeska Terpstra
    Hein Putter
    Rob A. E. M. Tollenaar
    Wilma E. Mesker
    J. Han J. M. van Krieken
    International Journal of Colorectal Disease, 2021, 36 : 2729 - 2737
  • [6] Does heterogeneity matter in the estimation of tumour budding and tumour stroma ratio in colon cancer?
    Eriksen, Ann C.
    Andersen, Johnnie B.
    Lindebjerg, Jan
    Christensen, Rene dePont
    Hansen, Torben F.
    Kjaer-Frifeldt, Sanne
    Sorensen, Flemming B.
    DIAGNOSTIC PATHOLOGY, 2018, 13
  • [7] Does heterogeneity matter in the estimation of tumour budding and tumour stroma ratio in colon cancer?
    Ann C. Eriksen
    Johnnie B. Andersen
    Jan Lindebjerg
    René dePont Christensen
    Torben F. Hansen
    Sanne Kjær-Frifeldt
    Flemming B. Sørensen
    Diagnostic Pathology, 13
  • [8] Tumour Budding and Tumour Stroma Ratio are Reliable Predictors for Death and Recurrence in Elderly Stage I Colon Cancer Patients
    Zengin, Mehmet
    PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (11)
  • [9] The Prognostic Value of Tumour-Stroma Ratio in Triple Negative Breast Cancer.
    Moorman, A. M.
    Vink, R.
    Heijmans, H. J.
    van der Palen, J.
    Kouwenhoven, E. A.
    CANCER RESEARCH, 2011, 71
  • [10] Prognostic impact of tumour laterality in early-stage colon cancer: A population-based study.
    Karim, Safiya
    Brennan, Kelly
    Nanji, Sulaiman
    Berry, Scott R.
    Booth, Christopher M.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345